Method and Use of α-Amino-β-Mercapto-Ethane Derivatives as Dicarbonyl Scavengers for Treatment of Conditions Resulting from Protein, Lipid, and DNA Damage by Jacobson, Elaine L. et al.
University of Kentucky
UKnowledge
Graduate Center for Nutritional Sciences Faculty
Patents Nutritional Sciences
7-9-2002
Method and Use of α-Amino-β-Mercapto-Ethane
Derivatives as Dicarbonyl Scavengers for
Treatment of Conditions Resulting from Protein,









Right click to open a feedback form in a new tab to let us know how this document benefits you.
Follow this and additional works at: https://uknowledge.uky.edu/nutrisci_patents
Part of the Medical Pharmacology Commons
This Patent is brought to you for free and open access by the Nutritional Sciences at UKnowledge. It has been accepted for inclusion in Graduate Center
for Nutritional Sciences Faculty Patents by an authorized administrator of UKnowledge. For more information, please contact
UKnowledge@lsv.uky.edu.
Recommended Citation
Jacobson, Elaine L.; Jacobson, Myron; Wondrak, Georg T.; and Laurean, Daniel Cervantes, "Method and Use of α-Amino-β-Mercapto-
Ethane Derivatives as Dicarbonyl Scavengers for Treatment of Conditions Resulting from Protein, Lipid, and DNA Damage" (2002).
Graduate Center for Nutritional Sciences Faculty Patents. 17.
https://uknowledge.uky.edu/nutrisci_patents/17
(12) United States Patent 
Jacobson et al. 
US006417235B2 
(10) Patent N0.: 
(45) Date of Patent: 
US 6,417,235 B2 












4,731,200 A * 
METHOD AND USE OF ot-AMINO-[3 
MERCAPTO-ETHANE DERIVATIVES AS 
DICARBONYL SCAVENGERS FOR 
TREATMENT OF CONDITIONS RESULTING 
FROM PROTEIN, LIPID, AND DNA DAMAGE 
Inventors: Elaine L. Jacobson; Myron K. 
Jacobson; Georg T. Wondrak; Daniel 
Cervantes Laurean, all of Tucson, AZ 
(Us) 
Assignee: University of Kentucky Research 
Foundation, Lexington, KY (US) 
Notice: Subject to any disclaimer, the term of this 
patent is extended or adjusted under 35 
USC 154(b) by 0 days. 
Appl. N0.: 09/836,552 
Filed: Apr. 16, 2001 
Related US. Application Data 
Provisional application No. 60/197,216, ?led on Apr. 14, 
2000. 
Int. Cl.7 ..................... .. A61K 31/13; A61K 31/195 
............... .. 514/665; 514/562 
Field of Search ................................ .. 514/562, 665 
References Cited 
U.S. PATENT DOCUMENTS 
3/1988 Lang et al. 
5,124,356 A * 6/1992 Purcell et al. 
5,126,442 A * 6/1992 Farmer et al. 
5,334,617 A * 8/1994 Ulrich et al. 
5,801,200 A * 9/1998 Bucala et al. 
OTHER PUBLICATIONS 
Database Embase, Abstract No. 1999376124, “Inhibition of 
nonenZymatic protein glycation and lipid . . . activity”, Life 
Sciences Oct. 1, 1999, 65/18—19, 1991—1993. 
Datbase Biosis, Abstract No. 1997:139942, “Strain of Rat 
Skin at Constant Load Creep . . . Agents”, Gerontology, 
1976, 23(2), 77—86. 
Database CAPLUS, Abstract No. 1988:545412, “In vitro 
and in vivo protection against phototoXic . . . agents 
WR—721 and WR—77913”, Photochem Photobiol. 1988, 
48/2, 235—8. 
* cited by examiner 
Primary Examiner—William R. A. Jarvis 
Assistant Examiner—Vickie Kim 
(74) Attorney, Agent, or F irm—Fulbright & J aWorski LLP 
(57) ABSTRACT 
Methods of inhibiting damage to proteins, lipids, and DNA 
by the use of penicillamines and other a-amino-[3,[3 
mercapto-B,[3-dimethyl-ethane compounds as dicarbonyl 
scavengers is disclosed. 
2 Claims, 19 Drawing Sheets 
U.S. Patent Jul. 9, 2002 Sheet 1 0f 19 US 6,417,235 B2 






AGE- PRODUCTS AND OTHER 
DAMAGE 0N PROTEINS, 
LIP!DS,AND NUCLEIC AClDS 

U.S. Patent Jul. 9, 2002 Sheet 3 0f 19 US 6,417,235 B2 
m2 +22
$258222 
E2 @2252 3565 
52c: , E25Eiésg 
3s: 
0. E55 
9\ /522g E  2885 :28»?3c 2m
*mmo<|cmo._en_ £2 95 
_ \ 
/ $2333 
32: 5 2aE  :3
Q a- 22 
22: 22:55 2: 6552 Gb20 3E2 5 0
Ea 5253 CEO: E; 38955:
82?? 2 22 :2
as L
2% =2: l 
U.S. Patent Jul. 9, 2002 Sheet 4 0f 19 US 6,417,235 B2 
AGE-INHIBITOR SCREENING 
AGE-FLUORESCENCE 
F/G‘. 4 <% OF CONTROL) 
0 50 I00 I50 
I | l 
H1/ADPR gm 
AMINOGUANIDINE ImM Zll 
5mM 2| 
10mM Z] 
Mia-201 1mM QE 
5mM Q 
10mM 3 
Mia-202 1mM 3m 
SmM 3 
mm 1 
Mia-203 1mM 2% 
SM Q 
10mM 5 
Mia-204 1mM 2223 
SM ZZZ} 
10mM 2E1 





Ni0-202 L- PENICILLAHINE 
Ni0-203 D-PENICILLANINE 
MiG-204 D-PENICILLAMINEDISULFIDE 
NiO-Z 05 N,S- ISOPROPYLIDENE-D'PENIClLLAMlNE 
U.S. Patent Jul. 9, 2002 Sheet 5 0f 19 US 6,417,235 B2 
46 DUPLICATE CLYCATION REACTIONS WITH TEST 
COMPOUNDS ON 96 WELL MICROTITER PLATE 
I 
AGE-FLUORESCENCE 0N DAYS 0 AND 5 
I I I 





FURTHER SCREENING BY PROTEIN CROSSLINIIING 
I 
BIOLOGICAL EVALUATION OF POSITIVES 
F765 
U.S. Patent Jul. 9, 2002 Sheet 6 0f 19 US 6,417,235 B2 
:25 E3
$323330 E 2:826:95: 565 
5 <6M5258
m 2Q3:
$327535 53::E@ 552 2 %.? 
U.S. Patent Jul. 9, 2002 Sheet 7 0f 19 US 6,417,235 B2 
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